Author

Ahmad Zarzour

Institution: Northwestern University

Observed institutions: Northwestern University, Cleveland Clinic, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Cincinnati, Damascus University

OpenAlex ID: A5108554103

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms

2012 · Mohamad Bassam Sonbol, Belal Firwana, et al. · Therapeutic Advances in Hematology · 98

Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

2013 · Mohamad A. Salkeni, Ahmad Zarzour, et al. · Journal of Neuro-Oncology · 56

The Effect of a Neutropenic Diet on Infection and Mortality Rates in Cancer Patients: A Meta-Analysis

2015 · Mohamad Bassam Sonbol, Belal Firwana, et al. · Nutrition and Cancer · 54

ROS1 amplification mediates resistance to gefitinib in glioblastoma cells

2015 · Hashim Aljohani, Robert F. Koncar, et al. · Oncotarget · 19

Tyrosine kinase inhibitors as a first‐line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed‐treatment comparison

2015 · Belal Firwana, Mohamad Bassam Sonbol, et al. · International Journal of Cancer · 14

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

2016 · Karam Al-Issa, Ahmad Zarzour, et al. · Blood · 5

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

2014 · Nagla Abdel Karim, Salma Musaad, et al. · Clinical Medicine Insights Oncology · 5

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

2014 · Nagla A. Karim, Hai Bui, et al. · Clinical Medicine Insights Oncology · 3

Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy

2015 · Ahmad Zarzour, Aziz Nazha, et al. · Blood · 2

The Impact of Different TP53 Mutations on Outcome in Patients with Myelodysplastic Syndromes (MDS)

2015 · Aziz Nazha, Mayur Narkhede, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

2014 · Ahmad Zarzour, Ali Tabarroki, et al. · Blood · 2

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

2014 · Ahmad Zarzour, Ali Tabarroki, et al. · Blood · 1

Impact of Non-JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

2014 · Jing Ai, Valeria Visconte, et al. · Blood · 1

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa).

2020 · Ahmad Zarzour, Alicia K. Morgans, et al. · Journal of Clinical Oncology

Adverse Effects of Androgen Deprivation in Elderly Men with Prostate Cancer

2019 · Ahmad Zarzour, Jeffrey W Shevach, et al. · Current Geriatrics Reports

Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa).

2019 · Ahmad Zarzour, Alicia K. Morgans, et al. · Journal of Clinical Oncology

The Complexity of Interpreting Genomic Data in Patients with Primary and Secondary Acute Myeloid Leukemia (AML)

2015 · Aziz Nazha, Ahmad Zarzour, et al. · Blood

ROS1 amplification mediates resistance to Gefitinib in glioblastoma multiforme cells

2015 · 박병선, Hashim M. Aljohani, et al.

Works count: 18

Citation count: 262

H-index: 5

I10-index: 5